Milestone Scientific Files 2024 Proxy Statement

TL;DR

MSNI proxy filed, annual meeting July 16. Vote on directors & auditors.

AI Summary

Milestone Scientific Inc. filed its definitive proxy statement on June 5, 2024, for its annual meeting of stockholders scheduled for July 16, 2024. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of auditors.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership and voting matters, enabling informed participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently introduce new financial risks.

Key Numbers

• 20240605 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
• 20240716 — Annual Meeting Date (Date of the shareholder meeting where votes will be cast.)

Key Players & Entities

• MILESTONE SCIENTIFIC INC. (company) — Registrant
• 20240605 (date) — Filing Date
• 20240716 (date) — Annual Meeting Date

FAQ

Filing Documents

• mlss20240603_def14a.htm (DEF 14A) — 326KB
• mlssproxy_page1.jpg (GRAPHIC) — 127KB
• mlssproxy_page2.jpg (GRAPHIC) — 95KB
• 0001437749-24-019311.txt ( ) — 633KB

Forward-Looking Statements

Forward-Looking Statements This Proxy Statement contains "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). These statements are based on our current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding actions to be taken by us. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements should be evaluated together with the many uncertainties that affect our business, particularly those mentioned in the risk factors in Item 1A of our 2023 Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. PROPOSAL 1 ELECTION OF DIRECTORS (ITEM 1 ON THE PROXY CARD) Our Board currently consists of seven (7) members, four (4) of whom are independent under the listing standards for independence of the NYSE American and under Rule 10A-3 under the Securities Exchange Act of 1934, as amended (which we refer to as the "Exchange Act"). Based upon the recommendation of the Nominating and Corporate Governance Committee of our Board, our Board determined to nominate each of the Company's current directors: Neil Goldman, Leonard A. Osser, Jan Adriaan (Arjan) Haverhals, Benedetta I. Casamento, Gian Domenico Trombetta, Michael McGeehan and Didier Demesmin for re-election at the Annual Meeting. Our Board and the Nominating Committee believe the directors nominated collectively have the experience, qualifications, attributes and skills to effectively oversee the management of the Company, including a high degree of personal and professional integrity, an ability to exercise sound business judgment on a broad range of issues, sufficient experience and background to have an appreciation of the issues facing the Company, a willingness t

View Full Filing

View this DEF 14A filing on SEC EDGAR